A recent study published in Cell Systems sought to debunk one of the most common myths about dogs: much to our surprise, one “dog year” does not equal seven “human years.” ... ( read original story ...)
How Face Yoga can be a ‘powerful tool’ for anti-aging and relieving stress during the coronavirus pandemic
Fumiko Takastu explains her Face Yoga method and how it can help people to feel and look stress-free while at home. ( read original story ...)
How daily Face Yoga practice helps anti-aging and reduces stress
Fumiko Takastu shows Yahoo Life’s Kerry Justich some basic poses that target tension caused by stress and signs of aging that people can practice from home. ( read original story ...)
AbbVie (ABBV) Gets FDA Nod for Another Botox Label Expansion
AbbVie (ABBV) wins the FDA nod for an expanded use of Botox to treat spasticity in pediatric patients aged two years and above including those with lower limb spasticity caused by cerebral palsy. ( read original story ...)
Botox, Keytruda Get FDA Approval For New Uses, BVXV Abuzz, First Droopy Eyelid Treatment Is Here
Today's Daily Dose brings you news about Altimmune's AdCOVID vaccine, the growing list of approved indications for AbbVie's Botox, an update on Aldeyra's Dry Eye disease drug candidate Reproxalap and ... ( read original story ...)
FDA OKs expanded use of Allergan’ Botox for pediatric patients with muscle stiffness
The FDA has approved AbbVie (NYSE:ABBV) company, Allergan's sBLA that supports expanded use of BOTOX (onabotulinumtoxinA) for the treatment of spasticity (muscle stiffness) in pediatric patients 2 ... ( read original story ...)
AbbVie : FDA Oks Expanded BOTOX Label For Treatment Of Pediatric Patients With Spasticity
(RTTNews) - Allergan, an AbbVie (ABBV) company, said that the U.S. Food and Drug Administration approved a supplemental Biologics License Application or sBLA that supports expanded use of BOTOX for ... ( read original story ...)
FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity
Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental Biologics License Application (sBLA) that supports expanded use of ... ( read original story ...)
J&J Urged To Stop Selling Talc-Based Baby Powder Worldwide
In a boost for AbbVie (ABBV), a U.S. International Trade Commission judge this week made an initial determination that sales of a competing version of its best-selling Botox treatment should be ... ( read original story ...)